Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinoma

Published:2018-08-28 Issue:2 Volume:246 Page:244-253
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol

Author:

Chedgy Edmund CP¹,Vandekerkhove Gillian¹,Herberts Cameron¹,Annala Matti¹²,Donoghue Adam J³,Sigouros Michael³,Ritch Elie¹,Struss Werner¹,Konomura Saki¹,Liew Janet¹,Parimi Sunil⁴,Vergidis Joanna⁴,Hurtado-Coll Antonio¹,Sboner Andrea³,Fazli Ladan¹,Beltran Himisha³,Chi Kim N⁴,Wyatt Alexander W¹^ORCID

Affiliation:

1. Vancouver Prostate Centre, Department of Urologic Sciences; University of British Columbia; British Columbia Canada

2. Institute of Biosciences and Medical Technology; University of Tampere; Tampere Finland

3. Department of Medicine, Division of Hematology and Medical Oncology; Weill Cornell Medical College; New York NY USA

4. Department of Medical Oncology; British Columbia Cancer Agency; British Columbia Canada

Funder

Prostate Cancer Foundation

Prostate Cancer Canada

Terry Fox Research Institute

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.5137/fullpdf

Reference44 articles.

1. Contemporary incidence and cancer control outcomes of primary neuroendocrine prostate cancer: a SEER Database analysis;Zaffuto;Clin Genitourin Cancer,2017

2. Neuroendocrine prostate cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis - a systematic review and pooled analysis;Wang;J Clin Oncol,2014

3. Proposed morphologic classification of prostate cancer with neuroendocrine differentiation;Epstein;Am J Surg Pathol,2014

4. Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma;Tsai;BMC Cancer,2017

5. Platinum-based chemotherapy for variant castrate-resistant prostate cancer;Aparicio;Clin Cancer Res,2013

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis;Cells;2024-08-22

2. PROX1 drives neuroendocrine plasticity and liver metastases in prostate cancer;Cancer Letters;2024-08

3. Intracellular Osteopontin Promotes the Release of TNFα by Mast Cells to Restrain Neuroendocrine Prostate Cancer;Cancer Immunology Research;2024-06-12

4. The Genetic Basis of Neuroendocrine Neoplasms;Endocrinology;2024

5. Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma;Cancer and Metastasis Reviews;2023-07-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3